Welcome to our dedicated page for Ventas SEC filings (Ticker: VTR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Ventas, Inc. (NYSE: VTR) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as a healthcare-focused S&P 500 real estate investment trust. Through these filings, investors can review how Ventas reports on its portfolio of approximately 1,400 properties in North America and the United Kingdom, including senior housing communities, outpatient medical buildings, research centers and other healthcare facilities.
Current and historical Forms 8-K offer detailed information about material events affecting Ventas and its subsidiaries. Recent 8-K filings describe items such as the pricing and issuance of senior notes by Ventas Realty, Limited Partnership, amendments to unsecured term loan facilities guaranteed by Ventas, and announcements of quarterly results. These documents help readers understand the company’s capital structure, borrowing arrangements and operating performance disclosures.
Other SEC filings, such as annual reports on Form 10-K and quarterly reports on Form 10-Q, provide broader context on Ventas’s business, risk factors, REIT structure and segment performance. For a healthcare REIT like Ventas, these reports typically include discussions of its senior housing operating portfolio, outpatient medical and research assets, and the demographic and regulatory environment relevant to its properties.
Investors can also use SEC filings to track matters such as dividend practices, debt covenants, and the terms of public offerings or credit agreements. On Stock Titan, AI-powered tools summarize lengthy filings, highlight key sections and surface important changes across reporting periods, helping users interpret complex documents more efficiently. Real-time updates from the SEC’s EDGAR system mean that new Ventas filings, including 10-K, 10-Q, 8-K and related exhibits, are available promptly, while Form 4 and other ownership reports can be consulted to analyze insider transactions and equity-based compensation activity associated with VTR.
Ventas EVP and General Counsel Carey S. Roberts reported multiple stock transactions in Ventas, Inc. common stock. On February 11, 2026, Roberts completed an open-market sale of 35,532 shares at a weighted average price of $84.9971 per share, leaving 72,755 shares directly owned immediately after that sale.
On the same date, 30,241 shares were issued to Roberts from a 2023–2025 performance stock unit award under the 2022 Incentive Plan, increasing direct holdings to 102,996 shares. The company then withheld 13,394 shares at a reference price of $85.69 to cover taxes tied to that award, reducing direct ownership to 89,602 shares.
Roberts also received a new grant of 12,010 restricted stock units on February 11, 2026 at a reference price of $85.69, which are payable in stock and vest in three equal annual installments starting the month after each of the first three anniversaries of the grant date. Following these transactions, Roberts directly owned 101,612 Ventas shares.
Probst Robert F reported multiple insider transaction types in a Form 4 filing for VTR. The filing lists transactions totaling 82,579 shares at a weighted average price of $85.69 per share. Following the reported transactions, holdings were 169,759 shares.
Ventas, Inc. executive James Justin Hutchens, EVP Senior Housing and CIO, reported several equity award transactions in company common stock. He acquired 39,076 shares at $0 through the vesting of a 2023–2025 performance stock unit award under the 2022 Incentive Plan, and 17,310 shares were disposed of to cover related tax withholding at a share price of $85.69. He also received a new grant of 21,341 restricted stock units on February 11, 2026, which are payable in common stock and vest in three equal annual installments on the first day of the month following each of the first three anniversaries of the grant date. Following these transactions, Hutchens directly beneficially owned 200,573 shares of Ventas common stock.
Ventas, Inc.'s Chairman and CEO Debra A. Cafaro reported several equity compensation transactions in the company’s common stock. On February 11, 2026, she acquired 176,925 shares issued under a 2023–2025 performance stock unit award pursuant to the Ventas, Inc. 2022 Incentive Plan.
On the same date, 78,377 shares were disposed of to cover taxes on those performance shares, using a price of $85.69 per share as the applicable closing price. She also received a grant of 54,265 restricted stock units that are payable solely in common stock and vest in three equal annual installments starting after each of the first three anniversaries of the grant date.
Following these transactions, Cafaro directly beneficially owned 1,266,847 shares of Ventas common stock.
Ventas, Inc. executive Peter J. Bulgarelli reported equity compensation-related transactions in company common stock. On February 11, 2026, he acquired 31,602 shares issued for his 2023–2025 performance stock unit award at $0 per share, reflecting a stock-based incentive payout. To cover associated taxes, 13,998 shares were disposed of through a tax-withholding transaction at a price of $85.69 per share, based on the closing stock price. On the same date, he also received a grant of 11,410 restricted stock units at $85.69 that vest in three equal annual installments starting after the first three anniversaries of the grant. Following these transactions, he directly held 126,768 shares of Ventas common stock.
A shareholder of Ventas, Inc. (symbol VTR) has filed a Form 144 notice to sell 35,532 shares of common stock through Morgan Stanley Smith Barney LLC on the NYSE, with an approximate sale date of February 11, 2026 and an aggregate market value of $3,020,116.96 for the proposed sale.
The shares to be sold were acquired as restricted stock vesting under a registered plan from the issuer on several dates between 2021 and 2023, with each tranche received as compensation rather than for cash. The notice also confirms the seller’s representation that they are not aware of undisclosed material adverse information about the issuer’s operations.
Ventas, Inc. Chairman and CEO Debra A. Cafaro reported an automatic option exercise and share sale. On February 6, 2026, she exercised 10,322 stock options at an exercise price of $73.71 per share, receiving 10,322 shares of common stock.
That same day, she sold 10,322 common shares at a weighted average price of $82.2274 per share under a Rule 10b5-1 trading plan entered into on March 28, 2024. After these transactions, she directly owned 1,114,034 shares of Ventas common stock.
Ventas, Inc. amended its existing at-the-market equity program, increasing the aggregate gross sales price of common stock that may be issued under its Sales Agreement to $2,500,000,000, excluding shares previously sold.
The amendment also adds M&T Securities, Inc. as an additional sales agent. Shares that Ventas or forward purchasers may offer and sell under this program will be issued pursuant to an effective Form S-3 shelf registration statement and a related prospectus supplement. The company also filed a legal opinion from Davis Polk & Wardwell LLP regarding the validity of the common stock issuable under the program.
Ventas, Inc. is launching an at-the-market equity program for up to $2.5 billion aggregate gross sales price of its common stock. The company can sell shares from time to time through multiple sales agents or directly to them as principal, and may also use forward sale agreements with affiliated banks.
Ventas will receive net cash proceeds from shares it issues and from physical settlement of any forward sales, and plans to use the funds for working capital, acquisitions and investments, or repayment of existing debt. As of February 3, 2026, Ventas had 474,965,224 common shares outstanding.
Ventas, Inc. insider plans a new stock sale after recent transactions. A Form 144 notice reports a proposed sale of 10,322 shares of Ventas common stock through Merrill Lynch on the NYSE, with an indicated aggregate market value of $848,751.37 and 469,732,824 shares outstanding.
The shares to be sold were acquired on 02/06/2026 via a broker-assisted exercise of employee stock options. Over the prior three months, Debra Cafaro reported several Ventas stock sales, including 41,294 shares on 11/17/2025 and three separate 10,322-share transactions, with disclosed gross proceeds for each sale.